| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.44 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.36 | 0.03 |